Naveen Pemmaraju: Wonderful to spend time with our brilliant leukemia fellows
Naveen Pemmaraju shared the following on LinkedIn:
“Thank you to Guillermo Garcia-Manero MD & Tapan Kadia and the Leukemia Fellowship Program team including Mrs. Crystal Mullen for the kind invitation to speak this evening at the Leukemia Fellow Lecture Series on the topic of BPDCN! It was wonderful to spend time with our dedicated & brilliant Leukemia Fellows and conduct a nice Q&A after the lecture.”
Source: Naveen Pemmaraju/LinkedIn
More posts featuring Naveen Pemmaraju on oncodaily.com
Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.
His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023